Market Tracker

08/28 6:01pm ET

GenMark Diagnostics Inc (NASDAQ:GNMK)

10.02
Delayed Data
As of Aug 28
 +0.59 / +6.26%
Today’s Change
7.57
Today|||52-Week Range
14.40
-26.38%
Year-to-Date
No recent news for GenMark Diagnostics Inc.

Today’s Trading

Previous close9.43
Today’s open9.34
Day’s range9.34 - 10.10
Volume273,387
Average volume (3 months)211,027
Market cap$424.7M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+2.11%
Earnings growth (this year)-19.66%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+11.64%
P/E ratioNM
Price/Sales18.39
Price/Book5.38

Competitors

 Today’s
change
Today’s
% change
NEONeogenomics Inc+0.30+5.02%
NVTAInvitae Corp+1.44+15.25%
CTICCTi Biopharma Corp+0.03+1.91%
RDNTRadNet Inc-0.17-2.74%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$30.6M
Annual profit (last year)-$38.3M
Net profit margin-125.07%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
Chief Financial Officer
Scott Mendel
Corporate headquarters
Carlsbad, California

Forecasts